Pfizer Inc (NYSE:PFE)
| 32.08 Delayed Data As of Sep 28 |  -0.01 / -0.03%Today’s Change | 31.77 Today|||52-Week Range 54.93 | -37.39% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 13.3B | 14.0B | 13.1B | 13.3B | |
| Cost of Goods Sold | 2.3B | 2.7B | 2.0B | 2.2B | ||
| Depreciation And Amortization | 1.6B | 1.6B | 1.5B | 1.5B | ||
| Operating Expenses | Gross Income | 9.4B | 9.7B | 9.5B | 9.5B | |
| General Expenses | 5.5B | 6.4B | 5.0B | 5.3B | ||
| Research And Development | 2.0B | 2.4B | 1.7B | 1.8B | ||
| Total Operating Expenses | 9.4B | 10.7B | 8.6B | 9.1B | ||
| Non-Operating Expenses | Operating Income | 3.9B | 3.3B | 4.5B | 4.2B | |
| Extraordinary Credit | 335.0M | 194.0M | 154.0M | 49.0M | ||
| Extraordinary Charge | -291.0M | -4.2B | -510.0M | -180.0M | ||
| Interest Expense On Debt | 310.0M | 370.0M | 361.0M | 389.0M | ||
| Other Expenses | 465.0M | 128.0M | 475.0M | 399.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 4.2B | -946.0M | 4.3B | 4.1B | |
| Income Taxes | -66.0M | -563.0M | -433.0M | -915.0M | ||
| Minority Interest | -8.0M | -11.0M | -6.0M | -10.0M | ||
| Discontinued Operations | 11.0M | 0.00 | 0.00 | 0.00 | ||
| Net Income | 4.1B | -394.0M | 3.9B | 5.0B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 5.9B | 5.8B | 5.6B | 5.6B | |
| Shares To Calculate EPS Diluted | 6.0B | 5.8B | 5.8B | 5.7B | ||
| Earnings Per Share | EPS | $0.69 | -$0.07 | $0.68 | $0.89 | |
| EPS Diluted | $0.69 | -$0.07 | $0.68 | $0.89 | ||